T. Rowe Price Investment Management, Inc. Zoetis Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $151 Billion
- Q1 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 48,986 shares of ZTS stock, worth $8.05 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
48,986
Previous 3,627
1250.59%
Holding current value
$8.05 Million
Previous $591,000
1264.81%
% of portfolio
0.01%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ZTS
# of Institutions
2,112Shares Held
421MCall Options Held
1.98MPut Options Held
1.03M-
Vanguard Group Inc Valley Forge, PA41.6MShares$6.83 Billion0.13% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$6.05 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.8MShares$3.25 Billion0.14% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL15.9MShares$2.61 Billion2.42% of portfolio
-
Morgan Stanley New York, NY12.7MShares$2.1 Billion0.15% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $77B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...